EIGR logo

Eiger BioPharmaceuticals, Inc. (EIGR)

Profile

Full Name

Eiger BioPharmaceuticals, Inc.

Ticker

NASDAQ: EIGR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 30, 2014

Indexes

Not included

Website

http://www.eigerbio.com

Employees

56

Key Details

Price

$1.73

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$15.77M(+16.98% YoY)

Annual EPS

-$50.78(+27.04% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.73
    EIGR price is $1.73

    30-Day Relative Volume

    3.38
    EIGR 30-day relative volume is 3.38

    Price Performance

    Price Most recent change

    -
    EIGR price change on Jun 17, 2025 is unknown

    Price YTD change

    -
    EIGR price ytd change is unknown

    Price 1-year change

    -85%
    EIGR price is down -85% year-on-year

    Price 3-year change

    -99.33%
    EIGR price is down -99.33% over the past 3 years

    Price Range

    Price All-time high

    $12712.50
    EIGR price is currently -99.99% below its historical high of $12712.50

    Price 3-year low

    $1.10
    EIGR price is currently +56.82% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.55M
    EIGR market capitalization is $2.55 million

    Market cap 3-year change

    -99.33%
    EIGR market capitalization is down -99.33% over the past 3 years

    Market cap All-time high

    $650.15M
    EIGR market capitalization is currently -99.61% below its historical high of $650.15 million

    Market cap sector rank

    -
    EIGR market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    EIGR {parameterFullLabel} has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +0.95%
    EIGR shares outstanding is up +0.95% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    2.80
    EIGR beta is 2.80

    200-day SMA

    $6.47
    EIGR price is currently -73.32% below its 200-day simple moving average

    50-day SMA

    $8.33
    EIGR price is currently -79.29% below its 50-day simple moving average

    RSI

    34.32
    EIGR 14-day relative strength index is 34.32

    Volume

    3.38
    EIGR 30-day relative volume is 3.38

    ATR

    $0.78
    EIGR average true range is $0.78

    10-day Historical Volatility

    400.14%
    EIGR 10-day historical volatility is 400.14%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $15.77M
    EIGR annual revenue is $15.77 million

    Revenue Analysts estimate

    $25.22M
    EIGR annual revenue is currently -37.46% lower than the consensus analysts' forecast

    Revenue 1-year change

    +16.98%
    EIGR annual revenue is up +16.98% year-on-year

    Revenue Sector rank

    -
    EIGR annual revenue is unknown

    EPS

    EPS

    -$50.78
    EIGR annual earnings per share is -$50.78

    EPS Analysts estimate

    -$15.60
    EIGR annual earnings per share is currently +225.51% higher than the consensus analysts' forecast

    EPS 1-year change

    +27.04%
    EIGR annual earnings per share is up +27.04% year-on-year

    EPS Sector rank

    -
    EIGR annual earnings per share is unknown

    Profit

    Gross profit

    $15.75M
    EIGR annual gross profit is $15.75 million

    Gross margin

    99.85%
    EIGR annual gross profit margin is 99.85%

    Operating profit

    -$71.79M
    EIGR annual operating income is -$71.79 million

    Operating margin

    -455.12%
    EIGR annual operating profit margin is -455.12%

    Net income

    -$74.96M
    EIGR annual net profit is -$74.96 million

    Net margin

    -
    EIGR annual net profit margin value is unknown

    Expenses

    Total expenses

    $87.56M
    EIGR annual total expenses is $87.56 million

    Operating expenses

    $87.53M
    EIGR annual total operating expenses is $87.53 million

    Cost of goods sold

    $24.00K
    EIGR annual cost of goods sold is $24.00 thousand

    Selling, general & administrative expenses

    $25.20M
    EIGR annual SGA is $25.20 million

    Depreciation and amortization

    $750.00K
    EIGR annual depreciation & amortization is $750.00 thousand

    Interest expense

    $5.47M
    EIGR annual interest expense is $5.47 million

    Income tax

    $6000.00
    EIGR annual income tax is $6000.00

    EBIT & EBITDA

    EBIT

    -$69.49M
    EIGR annual earnings before interest & taxes is -$69.49 million

    EBITDA

    -$68.74M
    EIGR annual EBITDA is -$68.74 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $38.83M
    EIGR annual total assets is $38.83 million

    Non current assets

    $987.00K
    EIGR annual long term assets is $987.00 thousand

    Current assets

    $37.84M
    EIGR annual total current assets is $37.84 million

    Cash and cash equivalents

    $25.44M
    EIGR annual cash & cash equivalents is $25.44 million

    Accounts receivable

    $1.68M
    EIGR annual accounts receivable is $1.68 million

    Inventory

    $1.56M
    EIGR annual inventory is $1.56 million

    Liabilities

    Total liabilities

    $53.28M
    EIGR annual total liabilities is $53.28 million

    Long term liabilities

    $0.00
    EIGR annual total long term liabilities is $0.00

    Current liabilities

    $53.28M
    EIGR annual total current liabilities is $53.28 million

    Accounts payable

    $2.12M
    EIGR annual accounts payable is $2.12 million

    Debt

    Total debt

    $41.20M
    EIGR annual total debt is $41.20 million

    Total debt 1-year change

    +2.5%
    EIGR annual total debt is up +2.5% year-on-year

    Long term debt

    $0.00
    EIGR annual long term debt is $0.00

    Short term debt

    $41.12M
    EIGR annual short term debt is $41.12 million

    Equity & Capital

    Shareholders equity

    -$14.46M
    EIGR annual stockholders equity is -$14.46 million

    Book value

    -$14.46M
    EIGR annual book value is -$14.46 million

    Retained earnings

    -$512.16M
    EIGR annual retained earnings is -$512.16 million

    Working capital

    -$15.45M
    EIGR annual working capital is -$15.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$74.55M
    EIGR annual cash flow from operations is -$74.55 million

    Cash from operations 1-year change

    +10.19%
    EIGR annual cash flow from operations is up +10.19% year-on-year

    Cash from investing

    $74.23M
    EIGR annual cash flow from investing activities is $74.23 million

    Cash from investing 1-year change

    +670.64%
    EIGR annual cash flow from investing activities is up +670.64% year-on-year

    Cash from financing

    $41.00K
    EIGR annual cash flow from financing activities is $41.00 thousand

    Cash from financing 1-year change

    -99.95%
    EIGR annual cash flow from financing activities is down -99.95% year-on-year

    CAPEX

    CAPEX

    $234.00K
    EIGR annual capital expenditures is $234.00 thousand

    CAPEX 1-year change

    -31.18%
    EIGR annual capital expenditures is down -31.18% year-on-year

    Free Cash Flow

    Free cash flow

    -$74.78M
    EIGR annual free cash flow is -$74.78 million

    Free cash flow 1-year change

    +10.28%
    EIGR annual free cash flow is up +10.28% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    99.85%
    EIGR annual gross profit margin is 99.85%

    Operating margin

    -455.12%
    EIGR annual operating profit margin is -455.12%

    Net margin

    -
    EIGR annual net profit margin value is unknown

    ROA & ROE

    ROA

    -193.07%
    EIGR annual return on assets is -193.07%

    ROE

    518.49%
    EIGR annual return on equity is 518.49%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    EIGR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    EIGR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.18
    EIGR price to book ratio is -0.18

    PB ratio Sector rank

    -
    EIGR price to book ratio is unknown

    PS Ratio

    PS ratio

    0.16
    EIGR price to sales ratio is 0.16

    PS ratio Sector rank

    -
    EIGR price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $18.32M
    EIGR enterprise value is $18.32 million

    Enterprise value Sector rank

    -
    EIGR enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -0.27
    EIGR EV/EBITDA is -0.27

    EV/EBITDA Sector rank

    -
    EIGR EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.71
    EIGR annual current ratio is 0.71

    Quick ratio

    0.68
    EIGR annual quick ratio is 0.68

    Leverage

    Debt to equity

    -2.85
    EIGR annual debt to equity ratio is -2.85

    Interest coverage ratio

    -12.71
    EIGR annual interest coverage ratio is -12.71

    Risk & Stability

    Piotroski F-Score

    4
    EIGR piotroski f-score is 4

    Altman Z-Score

    -24.42
    EIGR altman z-score is -24.42

    Analyst ratings

    Recent major analysts updates

    Aug 29, 23 Citigroup
    Buy
    Jun 30, 23 Baird
    Outperform
    Sep 7, 22 BTIG
    Buy
    Aug 9, 21 Citigroup
    Buy
    Apr 3, 20 Wedbush
    Outperform
    Jan 22, 20 Ladenburg Thalmann
    Buy
    Jun 26, 19 Citigroup
    Buy
    Jan 29, 19 Baird
    Outperform
    May 17, 18 BTIG Research
    Buy
    May 17, 18 BTIG
    Buy

    Institutional Ownership

    Screeners with EIGR included

    No data
    • What is the ticker symbol for Eiger BioPharmaceuticals, Inc.?
    • Does Eiger BioPharmaceuticals, Inc. pay dividends?
    • What sector is Eiger BioPharmaceuticals, Inc. in?
    • What industry is Eiger BioPharmaceuticals, Inc. in?
    • What country is Eiger BioPharmaceuticals, Inc. based in?
    • When did Eiger BioPharmaceuticals, Inc. go public?
    • Is Eiger BioPharmaceuticals, Inc. in the S&P 500?
    • Is Eiger BioPharmaceuticals, Inc. in the NASDAQ 100?
    • Is Eiger BioPharmaceuticals, Inc. in the Dow Jones?
    • When was Eiger BioPharmaceuticals, Inc.'s last earnings report?
    • When does Eiger BioPharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Eiger BioPharmaceuticals, Inc.?

    The ticker symbol for Eiger BioPharmaceuticals, Inc. is NASDAQ:EIGR

    Does Eiger BioPharmaceuticals, Inc. pay dividends?

    No, Eiger BioPharmaceuticals, Inc. does not pay dividends

    What sector is Eiger BioPharmaceuticals, Inc. in?

    Eiger BioPharmaceuticals, Inc. is in the Healthcare sector

    What industry is Eiger BioPharmaceuticals, Inc. in?

    Eiger BioPharmaceuticals, Inc. is in the Biotechnology industry

    What country is Eiger BioPharmaceuticals, Inc. based in?

    Eiger BioPharmaceuticals, Inc. is headquartered in United States

    When did Eiger BioPharmaceuticals, Inc. go public?

    Eiger BioPharmaceuticals, Inc.'s initial public offering (IPO) was on January 30, 2014

    Is Eiger BioPharmaceuticals, Inc. in the S&P 500?

    No, Eiger BioPharmaceuticals, Inc. is not included in the S&P 500 index

    Is Eiger BioPharmaceuticals, Inc. in the NASDAQ 100?

    No, Eiger BioPharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Eiger BioPharmaceuticals, Inc. in the Dow Jones?

    No, Eiger BioPharmaceuticals, Inc. is not included in the Dow Jones index

    When was Eiger BioPharmaceuticals, Inc.'s last earnings report?

    Eiger BioPharmaceuticals, Inc.'s most recent earnings report was on May 10, 2024

    When does Eiger BioPharmaceuticals, Inc. report earnings?

    The date for Eiger BioPharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page